This study will enroll subjects with qualifying limbal stem cell deficiency (LSCD). All subjects will receive CSB-001 investigational drug in either one or bot…

Limbal Stem Cell Deficiency

~Estimated

~$10 – $8,750

Claris Biotherapeutics, Inc.NCT06452316

A Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency

The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal s…

Limbal Stem Cell Deficiency

~Estimated

~$10 – $1,050

Claris Biotherapeutics, Inc.NCT07636590